CancerCareE is an independent cancer information resource. We don't make medical decisions — we make medical information easier to understand.

Independent cancer information. We don't make medical decisions.

Please don't send medical records through our contact channels. We don't receive or review them.

Don't send medical records — we don't receive them.

Medical Disclaimer: This page is a general language reference about ten Chinese medical terms that are dangerous to mistranslate. It does not interpret any individual pathology report, does not diagnose, and does not replace the explanation given by the pathologist who issued the report or your treating oncologist. The example on this page is fictional and clearly labeled.
Editorial & Review Information
Published2026-11-06
Last Reviewed2026-11-06
Reviewed ByCancerCareE Editorial Team
Content TypeLanguage Reference
Evidence LevelGeneral Information
⚠️ Chinese Medical Terms · Question-Based Reference

Which Chinese Medical Terms Are Most Dangerous to Mistranslate?

The most dangerous mistranslations in a Chinese pathology report are not obscure technical terms. They are familiar-looking words whose meaning is reversed: reading "不除外" as "excluded," "倾向" as "confirmed," or "阴性" as "benign." Each of these misreadings changes how you understand your report and what you ask your doctor next.

Published: 2026-11-06 7 sources cited Reviewed by the editorial team Independent · Non-commercial

Quick Answer

The most dangerous mistranslations in a Chinese pathology report fall into three groups: dropped negation ("不除外" read as "excluded"), confused certainty tiers ("倾向" read as "confirmed"), and misread immunohistochemistry results ("阴性" read as "benign" or "normal"). Any of these misreadings can shift your understanding of the report in the wrong direction. Modifier terms (符合, 考虑, 倾向, 不除外) express a hierarchy of diagnostic certainty, not a yes-or-no switch. "Positive" and "negative" in immunohistochemistry describe a staining reaction, not a benign-versus-malignant verdict. Reading any of these backwards means the questions you ask your doctor will be pointed in the wrong direction.

The Reality Check

"The dangerous Chinese terms are the obscure ones I don't recognize." — No. The dangerous terms are the ones you think you already understand. Because you do not feel the need to verify them, you read them backwards without noticing. The ten terms on this page are all common words. Each one has a specific misreading that changes the meaning of the report.

Who This Page Is NOT For

This page is not a tool to interpret your own pathology report, and it is not a substitute for the pathologist's explanation. It is for patients and families who have received a Chinese pathology report and want to understand which terms carry the highest risk of being misread — so they can verify them with their treating team rather than relying on a translation. Only the pathologist who issued the report, and your treating oncologist, can interpret the report for your specific case.

Why These Misreadings Are More Dangerous Than Unfamiliar Terms

When you encounter an unfamiliar technical term (for example, "腺泡状软组织肉瘤"), you know you do not know it, so you look it up or ask your doctor. But when you encounter "不除外," "倾向," or "阴性," you feel you already know what it means — so you do not verify it. The danger is precisely here: you think you have understood, but you have read it backwards.

A study of medical interpretation errors in pediatric encounters found an average of 31 interpretation errors per visit, of which 63% had potential clinical consequences. Errors by non-professional interpreters (77% with clinical consequences) were significantly higher than errors by professional hospital interpreters (53%). Language-level errors are not minor blemishes — they directly change the input to clinical decisions.

The same principle applies to reading a pathology report. A misread modifier term is not a cosmetic error. It changes what you think the report says, which changes what you ask your doctor, which changes what you find out.

Ten High-Risk Terms

不除外 bù chú wài
"Cannot exclude"
Common misreading: read as "excluded" or "no problem."

"不除外腺癌" means "the possibility of adenocarcinoma remains and cannot be excluded." Reading it as "adenocarcinoma has been excluded" reverses the meaning completely. A Chinese pathology teaching article says this term signals that the pathologist has low confidence and needs further testing to clarify. If you read it backwards, you may miss the follow-up test you should be asking about.

Correct reading: the possibility is still open and needs further investigation.
倾向 qīng xiàng
"Leaning toward"
Common misreading: read as "confirmed diagnosis."

"倾向" is a judgment between yes and no, leaning toward yes but with clearly insufficient confidence. A thyroid pathology teaching article explicitly states that "倾向于" does not equal "确诊" (confirmed diagnosis) and does not equal "early stage." Treating "倾向小细胞癌" as confirmed may lead you to make unnecessary psychological or practical arrangements before the immunohistochemistry results are available.

Correct reading: a directional leaning that still requires confirmation.
符合 fú hé
"Consistent with"
Common misreading: read as "100% confirmed."

"符合" is the highest certainty tier among the four modifiers, but it is still an intent-level diagnosis, not a "definite diagnosis." A hospital teaching article classifies pathology reports into four categories, and "符合" belongs to the "intent-level diagnosis" group, not the first category of "definite diagnosis." Treating "符合腺癌" as carved in stone may lead you to ignore the supplementary testing your doctor may still recommend.

Correct reading: a high-certainty directional judgment that still leaves room for supplementary testing.
阴性 yīn xìng
"Negative" (in immunohistochemistry)
Common misreading: read as "benign" or "no problem."

In immunohistochemistry, "negative" means the staining reaction did not detect the target substance — it does not mean "normal." Tencent Medical Encyclopedia states plainly that immunohistochemistry results "must never equate 'positive' with 'benign' or 'malignant'." For example, breast cancer that is negative for all three of ER, PR, and HER2 is called "triple-negative breast cancer" — which is precisely a type with limited treatment options, not a "benign" condition.

Correct reading: a description of a staining reaction, not a benign-versus-malignant verdict.
阳性 yáng xìng
"Positive" (in immunohistochemistry)
Common misreading: read as "malignant" or "more severe."

Again, "positive" is only a description of a staining reaction. Some positive markers may indicate a better treatment response (for example, ER-positive breast cancer can be treated with endocrine therapy) rather than a "more severe" condition. Equating "positive" with "malignant" may produce a fear about prognosis that the report does not actually support.

Correct reading: a description of a staining reaction whose clinical meaning depends on which marker is positive.
可疑 kě yí
"Suspicious for"
Common misreading: read as "confirmed" or "basically is."

"可疑" belongs to the same tier as "不除外" in pathology report classification — it calls for vigilance and verification. It is not a judgment approaching confirmation; it is a signal that triggers further testing.

Correct reading: a signal to verify, not a conclusion.
待除外 dài chú wài
"To be excluded" / "pending exclusion"
Common misreading: read as "already excluded" or "no need to worry."

The character "待" means "not yet completed." A teaching article places "待除外" alongside "待查" in the "ambiguous diagnostic conclusion" category. Reading it as "no need to handle" would skip the verification step that should still happen.

Correct reading: verification has not yet been completed and still needs to happen.
提示 tí shì
"Suggestive of"
Common misreading: read as "definitely is."

In a widely cited interpretation of pathology modifier terms, "提示" belongs with "考虑" and "倾向" as an intent-level diagnostic phrase, not a definite diagnosis. Reading "提示腺癌" as "it is adenocarcinoma" overestimates the report's certainty.

Correct reading: a directional suggestion that still requires confirmation.
可能性大 kě néng xìng dà
"Highly likely"
Common misreading: read as "definitely is."

"可能性大" belongs with "符合" in the intent-level diagnostic group, not the definite diagnosis group. It expresses "probabilistically high," not "certain."

Correct reading: probabilistically high, but not certain.
未见明确 wèi jiàn míng què
"No clear evidence of"
Common misreading: read as "there is no disease."

"未见明确" is a hedged statement: "under the current specimen and testing conditions, no clear evidence was seen." It does not equal "does not exist at all." If the specimen is limited or the test method has limited sensitivity, this phrasing may conceal a possibility that still needs further investigation.

Correct reading: a hedged statement about what the current specimen and test could detect — not an absolute negative.

Summary Table: Misreading vs. Correct Reading

Term Pinyin Approximate English Common misreading Correct reading
不除外 bù chú wài Cannot exclude "Excluded" / "no problem" Possibility still open; further testing needed
倾向 qīng xiàng Leaning toward "Confirmed" Directional leaning; needs confirmation
符合 fú hé Consistent with "100% confirmed" Highest modifier tier, but still intent-level
阴性 yīn xìng Negative (IHC) "Benign" / "normal" Staining reaction not detected
阳性 yáng xìng Positive (IHC) "Malignant" / "more severe" Staining reaction detected; meaning depends on marker
可疑 kě yí Suspicious for "Confirmed" / "basically is" Signal to verify
待除外 dài chú wài To be excluded "Already excluded" / "no need to worry" Verification not yet completed
提示 tí shì Suggestive of "Definitely is" Directional suggestion; needs confirmation
可能性大 kě néng xìng dà Highly likely "Definitely is" Probabilistically high, not certain
未见明确 wèi jiàn míng què No clear evidence of "There is no disease" Hedged statement about what the current specimen could detect
Important: This table is a language reference, not a statistical prediction for any individual case. The pathologist's own explanation, and your treating oncologist's interpretation, remain the final word.

A Fictional Example: How a Misreading Changes the Question

The example below is fictional. It is used only to show how the same term can lead to two different questions. It is not derived from any real patient's records.

Fictional Example — Not a Real Report
Report text (fictional): "支气管活检组织,倾向小细胞癌,建议免疫组化进一步明确。"
Misreading: "Confirmed small cell carcinoma." → You begin searching small cell carcinoma survival rates and may overlook the doctor's mention of "waiting for immunohistochemistry results."
Correct reading: "The pathologist saw features supporting small cell carcinoma, but the confidence level only reached '倾向'. The next step is immunohistochemistry to raise the certainty." → The question you ask is: "When will the immunohistochemistry results be available? What should I do while waiting?"

How to read this example: The same word leads to two different modes. The misreading puts you in "confirmed mode." The correct reading puts you in "verification mode." The second mode matches what the report actually says.

Questions to Bring to Your Doctor

These questions are educational. They are not an assessment of your case. Review the answers with your licensed oncologist and, where appropriate, the pathologist who issued the report.

1

Which modifier term appears in my report?

符合, 考虑为, 倾向, 不除外, 可疑, or 可能性大 — and what level of certainty does it correspond to?

2

What follow-up test does the report recommend?

Immunohistochemistry, special staining, or re-biopsy — and what is the expected timeline?

3

If the report says 阴性 or 阳性 (immunohistochemistry), what does it mean in my case?

Does it change the diagnosis, the treatment options, or the prognosis — and how?

4

Is this the final report, or will there be a supplementary report?

When is the supplementary report expected, and how can I obtain a copy?

5

If the follow-up test does not support the current leaning, what is the alternative plan?

Would a second pathology opinion or re-biopsy be considered?

Continue Your Research

Related reference pages on Chinese medical documents and cancer diagnosis.

Frequently Asked Questions

Why are these ten terms more dangerous than other Chinese medical terms?

Because they look familiar. When you see an unfamiliar technical term, you know to look it up. When you see "不除外" or "倾向," you feel you already understand it — so you do not verify it. The danger is precisely that the misreading happens without you noticing. The ten terms on this page all have a specific reading that reverses or overstates the report's meaning.

Does "阴性" mean the tumor is benign?

No. In immunohistochemistry, "阴性" (negative) means the staining reaction did not detect the target substance. It does not mean "benign" or "normal." A tumor can be negative for one marker and positive for another, and the clinical meaning depends on which marker is being discussed. For example, "triple-negative breast cancer" (ER/PR/HER2 all negative) is a type with limited treatment options, not a benign condition.

If my report says "符合," is that a final diagnosis?

"符合" is the highest certainty tier among the four modifier terms, but it is still an intent-level diagnosis, not a "definite diagnosis." In a common hospital teaching classification, "符合" belongs to the "intent-level diagnosis" group, not the first category of "definite diagnosis." Your doctor may still recommend supplementary testing. Treating "符合" as carved in stone may lead you to ignore those recommendations.

Does "不除外" mean I definitely have the disease?

No. "不除外" means "cannot exclude" — the possibility remains open, but the current specimen or evidence is not enough to support a directional judgment. It does not mean "you definitely have it," and it does not mean "you definitely do not have it." The function of the term is to trigger further testing or re-biopsy, not to give you a conclusion.

Can an AI tool help me read these terms?

With caution, and never as the only step. A 2025 study on AI translation of pathology reports found that while most answers were satisfactory, a small number of cases included critical errors — including misreading a benign tumor as malignant. The study concluded that patients should not rely entirely on AI tools to interpret pathology reports. This page is a language reference, not an AI interpretation of your report; the meaning of these terms in your case should be confirmed with the pathologist or your treating oncologist.

Where can I find the full list of Chinese medical document reference pages?

This page is part of a series of question-based reference pages on Chinese medical documents. Related pages cover pathology certainty terms, drug-name matching, discharge summaries, laboratory reports, imaging reports, and molecular reports. You can find the full list on the Evidence Hub.

Sources & References

  1. 华夏病理网. 病理报告的修饰词"符合、考虑、倾向、不除外". 2020-01-02. ipathology.cn ↗
  2. xxdsdyrmyy.cn. 【健康科普】读懂病理医生的"潜台词"——您的报告属于这四类中的哪一种?2025-10-19.
  3. nhrmyy.com. 如何解读病理报告(一). 2021-01-31.
  4. 39健康网. 甲状腺倾向于乳头状癌是早期吗,别被倾向二字误导. 2026-08-02. 39.net ↗
  5. 腾讯医典. 免疫组化检查:如何解读结果. baike.qq.com ↗
  6. 微信公众平台. 健康科普丨病理报告中的小细节与大学问. 2023-10-19.
  7. Flores G, et al. Errors in medical interpretation and their potential clinical consequences in pediatric encounters. Pediatrics. 2003;111(1):6-14. PubMed ↗
Final Medical Disclaimer: CancerCareE is an independent information reference. We do not provide medical services, diagnose or treat disease, receive medical records, act as an intermediary between patients and treatment centers, or guarantee access, eligibility, or outcomes. The information on this page is a general language reference about high-risk Chinese medical terms and is not a substitute for consultation with a licensed physician or the pathologist who issued your report. The example on this page is fictional and is not derived from any real patient's records. All treatment decisions must be made by licensed physicians together with their patients, based on a full review of each individual's clinical situation.